| abstract |
The present invention provides antibodies that specifically bind OX40 (CD134), which may be referred to as OX40 antibodies, anti-OX40 or anti-OX40 antibodies. Antibodies of the invention that specifically bind to OX40 include mammals (humans, primates, etc.), humanized and chimeric anti-OX40 antibodies. Antibodies and antibody subsequences (fragments) of the invention that specifically bind to OX40 include purified and isolated antibodies, as well as pharmaceutical formulations thereof, and are useful in a variety of methods including therapeutic methods, screening methods, and detection methods.n n n n OX40 antibody, subsequence, fragment, CD134, mammal, pharmaceutical formulation, treatment, screening, detection |